Combined use of an antigen and antibody detection enzyme-linked immunosorbent assay for cysticercosis as tools in an epidemiological study of epilepsy in Burundi

Tropical Medicine and International Health

Volumn 12, Issue 7, 2007, Pages 895-901

  Prado Jean, A ^a   Kanobana, K ^b   Druet Cabanac, M ^a   Nsengyiumva, G ^c   Dorny, P ^b   Preux, P M ^a   Geerts, S ^b  

^a UNIVERSITÉ DE LIMOGES   (France)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c Centre National de Référence en Matière de VIH SIDA Au Burundi   (Burundi)

Author keywords

Burundi; Case control study; Cysticercosis; Diagnosis; Enzyme linked immunosorbent assay; Epilepsy

Indexed keywords

ANTIBODY; ANTIGEN; DETECTION METHOD; EPIDEMIOLOGY; IMMUNOASSAY; NERVOUS SYSTEM DISORDER; PARASITIC DISEASE; SERUM;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; BURUNDI; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROCYSTICERCOSIS; PARASITE TRANSMISSION; RISK ASSESSMENT; SCHOOL CHILD; TAENIA SOLIUM; TIME SERIES ANALYSIS;

ADULT; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; BURUNDI; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FEMALE; HUMANS; MALE; NEUROCYSTICERCOSIS; RISK FACTORS; SEX DISTRIBUTION;

AFRICA; BURUNDI; CENTRAL AFRICA; KIREMBA; SUB-SAHARAN AFRICA;

TAENIA SOLIUM;

EID: 34347238210     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2007.01860.x     Document Type: Article

References (35)

1. Carpio A Hauser WA (2002) Prognosis for seizures recurrence in patients with newly diagnosed neurocysticercosis. Neurology 10, 1730 1734.
2. Correa D, Sarti E, Tapiaromero R et al. (1999) Antigens and antibodies in sera from human cases of epilepsy or taeniasis from an area of Mexico where Taenia solium cysticercosis is endemic. Annals of Tropical Medicine and Parasitology 93, 69 74.
3. Del Brutto OH, Rajshekhar V, White AC et al. (2001) Proposed diagnostic criteria for neurocysticercosis. Neurology 57, 177 183.
4. Dorny P, Vercammen F, Brandt J et al. (2000) Sero-epidemiological study of Taenia saginata cysticercosis in Belgian cattle. Veterinary Parasitology 88, 43 50.
5. Dorny P, Brandt J Geerts S (2004a) Immunodiagnostic approaches for detecting Taenia solium. Trends in Parasitology 20, 259 260.
6. Dorny P, Phiri IK, Vercruysse J et al. (2004b) A Bayesian approach for estimating values for prevalence and diagnostic test characteristics of porcine cysticercosis. International Journal for Parasitology 34, 569 576.
7. Erhart A, Dorny P, De NV et al. (2002) Taenia solium cysticercosis in village in northern Viet Nam: seroprevalence study using an ELISA for detecting circulating antigen. Transactions of the Royal Society of Tropical Medicine and Hygiene 96, 270 272.
8. Garcia HH, Parkhouse RM, Gilman RH et al. (2000) Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 673 676.
9. Garcia HH, Evans CA, Nash TE et al. (2002) Current consensus guidelines for treatment of neurocysticercosis. Clinical and Microbiological Review 15, 747 756.
10. Garcia HH, Gilman R, Gonzalez A et al. (2003) Hyperendemic human and porcine Taenia solium infection in Peru. American Journal of Tropical Medicine and Hygiene 68, 268 275.
11. Guerra G, Flisser A, Canedo L Laclette JP (1982) Biochemical immunological characterization of antigen B purified from cysticercosis of Taenia solium. In : Cysticercosis, Present State of Knowledge and Perspective (eds A Flisser, K Willms, JP Laclette, C Larralde, C Ridaura F Beltran) Academic Press, New York/London/Paris, pp. 437 451.
12. Houinato D, Ramanankandrasana B, Adjide C et al. (1998) Seroprevalence of cysticercosis in Benin. Transactions of the Royal Society of Tropical Medicine and Hygiene 92, 621 624.
13. ILAE (1989) Commission on classification and terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30, 389 399.
14. ILAE (1993) Commission on epidemiology and prognosis of the International League Against Epilepsy. Guidelines for epidemiologic studies on epilepsy. Epilepsia 34, 592 596.
15. Ito A, Yamasaki H, Nakao N et al. (2003) Multiple genotypes of Taenia solium - ramifications for control. Acta Tropica 87, 95 102.
16. Newell E, Vyungimana F Bradley JE (1997a) Epilepsy, retarded growth and onchocerciasis, in two areas of different endemicity of onchocerciasis in Burundi. Transactions of the Royal Society of Tropical Medicine and Hygiene 91, 525 527.
17. Newell E, Vyungimana F, Geerts S et al. (1997b) Prevalence of cysticercosis in epileptics and members of their families in Burundi. Transactions of the Royal Society of Tropical Medicine and Hygiene 91, 389 391.
18. Ngoungou EB, Dulac O, Poudiougou B et al. (2006a) Epilepsy as a consequence of cerebral malaria in area in which malaria is endemic in Mali, West Africa. Epilepsia 47, 873 879.
19. Ngoungou EB, Koko J, Druet-Cabanac M et al. (2006b) Cerebral malaria and sequelar epilepsy: first matched case-control study in Gabon. Epilepsia 47, 2147 2153.
20. Nguekam, Zoli AP, Ongolo-Zogo P et al. (2003a) Follow-up of neurocysticercosis patients after treatment using an antigen detection ELISA. Parasite 10, 65 68.
21. Nguekam, Zoli AP, Vondou L et al. (2003b) Kinetics of circulating antigens in pigs experimentally infected with Taenia solium eggs. Veterinary Parasitology 111, 323 332.
22. Nguekam, Zoli AP, Zogo PO et al. (2003c) A seroepidemiological study of human cysticercosis in West Cameroon. Tropical Medicine and International Health 8, 144 149.
23. Nicoletti A, Bartoloni A, Reggio A et al. (2002) Epilepsy, cysticercosis, and toxocariasis: a population-based case-control study in rural Bolivia. Neurology 58, 1256 1261.
24. Nsengiyumva G, Druet-Cabanac M, Ramanankandrasana B et al. (2003) Cysticercosis as a major risk factor for epilepsy in Burundi, East Africa. Epilepsia 44, 950 955.
25. Nzisabira L, Nsengiyumva G, Bouteille B et al. (1992) La cysticercose dans la province de Kayanza (Burundi). Bulletin de la Société de Pathologie Exotique 85, 374 377.
26. Pal DK, Carpio A Sanders JW (2000) Neurocysticercosis and epilepsy in developing countries. Journal of Neurology, Neurosurgery and Psychiatry 68, 137 143.
27. Pawlowski ZS Murrell KD (2001) Taeniasis and cysticercosis. In : Foodborne disease handbook, Vol 2: Viruses, Parasites, Pathogens, and HACCP (eds YH Hui, SA Sattar, KD Murrell, WK Nip PS Stanfield) Marcel Dekker, New York, pp. 217 227.
28. Preux PM Druet-Cabanac M (2005) Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurology 4, 21 31.
29. Preux PM, Melaku Z, Druet-Cabanac M et al. (1996) Cysticercosis and neurocysticercosis in Africa: current status. Neurological Infections and Epidemiology 1, 63 68.
30. Preux PM, Druet-Cabanac M, Debrock C et al. (2000) Questionnaire d'investigation de l'épilepsie dans les pays tropicaux. Bulletin de la Société de Pathologie Exotique 93, 276 278.
31. Sciutto E, Fragoso G, Fleury A et al. (2000) Taenia solium disease in humans and pigs: an ancient parasitosis disease rooted in developing countries and emerging as a major health problem of global dimensions. Microbes and Infection 2, 1875 1890.
32. Sokal RR Rohlf JF 1981) Biometry: The Principals and Practice of Statistics in Biological Research. W.H. Freeman Company, New York, p. 859.
33. Sotelo J Flisser A 1997) Neurocysticercosis practical treatment guidelines. CNS Drugs 7, 17 25.
34. World Health Organization (2002) Control of neurocysticercosis. Provisional agenda of the 55th World Health Assembly, Geneva, pp. 1 3.
35. Zoli A, Nguekam, Shey-Njila O et al. (2003) Neurocysticercosis and epilepsy in Cameroon. Transactions of the Royal Society of Tropical Medicine and Hygiene 97, 683 686.